Michael O'Neill Montgomery,Ahmad Naim,Susan Snodgrass
申请号：
US16276157
公开号：
US20190255053A1
申请日:
2019.02.14
申请国别(地区):
US
年份:
2019
代理人:
摘要：
This disclosure relates to JAK1 pathway inhibitors and the use thereof in treating cytokine-related diseases or disorders such as cytokine release syndrome (CRS), hemophagocytic lymphohistiocytosis (HLH), macrophage activation syndrome (MAS), and CAR-T-cell-related encephalopathy syndrome (CRES).
